← Back to Search

Hormones and Pain Sensitivity for Migraine (IHS Trial)

N/A
Recruiting
Led By Hadas Nahman-Averbuch, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

IHS Trial Summary

This trial studies how hormones affect pain and migraine severity in both men and women.

Who is the study for?
This study is for boys and girls aged 11-15 who speak English. It includes two groups: one with adolescents diagnosed with migraines, and a control group of healthy individuals without a family history of migraines. Pregnant or breastfeeding teens, those with chronic pain (other than migraines), neurological issues, psychiatric conditions, or on hormone-altering meds can't participate.Check my eligibility
What is being tested?
The trial examines how puberty hormones affect pain sensitivity and migraine severity in adolescents. Participants will undergo tests using thermal and pressure stimuli to measure pain response, complete a migraine disability assessment (PedMIDAS), have their hormonal levels checked, and assess pubertal status.See study design
What are the potential side effects?
Since the interventions involve non-invasive testing methods like temperature exposure, pressure application, questionnaires about headaches impact on daily life (PedMIDAS) rather than medication or invasive procedures; significant side effects are not expected.

IHS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Conditioned pain modulation (CPM) response
Sex Hormones
Secondary outcome measures
Migraine specific measures
Sex hormone assessments

IHS Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: MigraineActive Control8 Interventions
Adolescents with a migraine diagnosis
Group II: Healthy controlPlacebo Group7 Interventions
Adolescents without a migraine diagnosis

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,935 Previous Clinical Trials
2,299,710 Total Patients Enrolled
1 Trials studying Migraine
250 Patients Enrolled for Migraine
International Headache SocietyUNKNOWN
2 Previous Clinical Trials
272 Total Patients Enrolled
Hadas Nahman-Averbuch, PhDPrincipal InvestigatorWashington University School of Medicine
3 Previous Clinical Trials
570 Total Patients Enrolled
1 Trials studying Migraine
250 Patients Enrolled for Migraine

Media Library

Migraine Clinical Trial Eligibility Overview. Trial Name: NCT05738213 — N/A
Migraine Research Study Groups: Migraine, Healthy control
Migraine Clinical Trial 2023: Migraine Highlights & Side Effects. Trial Name: NCT05738213 — N/A
Migraine 2023 Treatment Timeline for Medical Study. Trial Name: NCT05738213 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age criteria for this research encompass octogenarians?

"For this medical trial, only individuals aged 11 to 15 years old may be accepted as participants."

Answered by AI

Are any individuals being enrolled in this clinical experiment at present?

"Per the clinicaltrials.gov website, this study is actively seeking participants; it was initially posted on January 10th of 2023 and recently modified on February 20th of that same year."

Answered by AI

Who meets the criteria for enrollment in this clinical trial?

"This study is seeking 100 pre-adolescent females, aged 11 to 15 who are fluent in English and either suffering from migraine or healthy without any diagnosis."

Answered by AI

How many participants are involved in this research endeavor?

"Affirmative, the information on clinicaltrials.gov verifies that this medical experiment is presently enrolling candidates. This endeavor was first put up on 1/10/2023 and updated most recently on 2/20/2023. The trial requires 100 participants to be admitted from a single location."

Answered by AI
~35 spots leftby Jan 2025